Funding and Investments

Oct 08, 2015
Through the Glycoscience Program, the National Institute of Health will contribute $10 million to advance the study of carbohydrates and the compounds that interact with them.
Sep 22, 2015
By BioPharm International Editors
Six grants from the NIH will help identify variants in the genome’s regulatory regions that affect disease risk, using new computational approaches.
Jun 18, 2015
By BioPharm International Editors
GSK announces it will invest $95 million to launch a US-based non-profit research institute, Altius, to research technologies and approaches in understanding gene control.
Jan 22, 2015
By BioPharm International Editors
Syncona and Kite Pharma announced separate investments into T-cell therapies to fight cancerous tumors.
Dec 01, 2014
BioPharm International
By BioPharm International Editors
Dalton Pharma Services announced it was awarded funding from ISTPCanada for its project to develop vaccines for respiratory syncytial virus and parainfluenza type 3.
Oct 24, 2014
Unum Therapeutics raised $12 million in Series A funding for its development of antibody-coupled T cell receptors (ACTRs) for the treatment of nonspecific tumor cells.
Jul 02, 2014
By BioPharm International Editors
OCE and OBI partner with CQDM on $3 million inter-provincial drug discovery innovation programs.
Jul 01, 2014
BioPharm International
By BioPharm International Editors
Gene therapy, immune-oncology, and digital healthcare technologies offer investors promise for innovation investments.
Apr 22, 2014
By BioPharm International Editors
Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.
Apr 01, 2014
BioPharm International
By BioPharm International Editors
Life-sciences companies continue upward momentum in 2014.
native1_300x100
lorem ipsum